NCT06911281View on ClinicalTrials.gov

Combined Therapy of Photoelectric Instruments and Human Umbilical Cord Mesenchymal Stem Cells for Pigmentary Disorders

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Mesenchymal Stem Cells；Pigmentary Disorders
Interventions
COMBINATION_PRODUCT

Mesenchymal Stem Cells；755nm picosecond laser treatment

Stem Cell Treatment Group 1 received intravenous infusion of MSCs followed by multi-point injection into the melasma area, combined with 755nm picosecond laser treatment. Stem Cell Treatment Group 2 received multi-point injection of MSCs into the melasma area, combined with 755nm picosecond laser treatment. The Control Group only received 755nm picosecond laser treatment.

All Listed Sponsors
collaborator

ARSMO(Hainan) International Plastic & Aesthetic Hospital Company Limited

UNKNOWN

lead

Shanghai East Hospital

OTHER